Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of ascorbic acid with NAB-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy [Phase 1]
Phase 1 study evaluating BI 765883 dose in advanced pancreatic cancer, with or without chemotherapy; the trial is terminated with posted res…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) [Phase 2, Phase 3]
A study evaluating Navlimetostat (BMS-986504) with nab-paclitaxel and gemcitabine versus placebo with nab-paclitaxel and gemcitabine in untr…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
A Phase 3 clinical trial comparing quemliclustat plus chemotherapy versus placebo plus chemotherapy in metastatic pancreatic ductal adenocar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 trial of daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active-not-recruiting, indicat…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue [Phase 2, Phase 3]
Clinical trial update for Ponsegromab in adults with cachexia due to metastatic pancreatic ductal adenocarcinoma (phases 2 and 3) currently …
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial evaluating chemotherapy with or without INCB161734 in previously untreated KRAS G12D-mutated metastatic pancreatic ductal aden…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers [Phase 1]
A Phase I trial evaluating [177Lu]Lu-NNS309, a radiopharmaceutical, in multiple advanced cancers including pancreatic ductal adenocarcinoma,…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating nab-paclitaxel plus cisplatin and gemcitabine in untreated metastatic pancreatic ductal adenocarcinoma; results hav…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies [Phase 1]
Pfizer's Phase 1 trial of PF-08046037 alone or with sasanlimab in advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma [NA]
Clinical trial update indicates that a study of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for inoperable pancreatic duc…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for locally advanced pancreatic cancer that cannot be removed su…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma [NA]
A clinical trial investigating surgical resection for synchronous pulmonary or hepatic oligometastatic pancreatic ductal adenocarcinoma has …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
A completed Travera Inc trial evaluating TraveraRTGx and a tumor-cell biomarker intended to guide rapid therapy decisions across multiple ca…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors [Phase 1, Phase 2]
GEN1042 is being evaluated in a Phase 1/2 safety study with indications across malignant solid tumors, including non-small cell lung cancer,…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors [Phase 1]
Phase 1 study update for RMC-6291 monotherapy in KRASG12C-mutant solid tumors, outlining dose-escalation and dose-expansion cohorts in subje…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
A completed study comparing TDTP-RECIST with RECIST 1.1 and other volumetric methods to evaluate therapeutic response in irregular malignant…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]
Clinical trial update describes a Phase 1 dose-escalation study of [225Ac]-FPI-2068 in adults with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study of ERAS-007 in patients with advanced gastrointestinal malignancies, sp…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer [Phase 1]
Phase 1 trial of NBTXR3 activated by radiation therapy for borderline resectable or locally advanced pancreatic cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation [Phase 1]
AstraZeneca's Phase I/IIa study of AZD0022 in KRASG12D-mutant tumors has been terminated. The study enrolled adults with advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP) [Phase 1, Phase 2]
An update on a Phase 1/Phase 2 trial evaluating neoadjuvant TAMP (PRISM-TAMP) for pancreatic ductal adenocarcinoma, with attention to tumor …
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors [Phase 1, Phase 2]
A clinical trial update indicates that ELI-002 7P is being studied in KRAS/NRAS-mutated solid tumors in Phase 1/Phase 2, with the study curr…